|
Sleep Apnea in a Non-Clinical Population Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Sleep Apnea in a Non-Clinical Population conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Sleep Apnea in a Non-Clinical Population Clinical research trials and Sleep Apnea in a Non-Clinical Population health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Sleep Apnea in a Non-Clinical Population. Sleep Apnea in a Non-Clinical Population Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Sleep Apnea in a Non-Clinical Population clinical trial. Subjects frequently get the best healthcare possible for their Sleep Apnea in a Non-Clinical Population condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Sleep Apnea in a Non-Clinical Population  Sleep Apnea in a Non-Clinical Population
Sleep Apnea in a Non-Clinical Population
For Condition: Lung Diseases,Heart Diseases,Sleep Apnea Syndromes,Cardiovascular Diseases,Obesity,Hypertension
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To investigate the causes, consequences and quantitation of sleep disordered breathing (SDB).
Details: BACKGROUND: The study utilized an extremely rich source of data collected on the Wisconsin Sleep Cohort, one of the largest cohort studies of SDB and one with the longest periods of follow-up, to address a broad array of questions related to the pathogenesis and risk of SDB in the general community. The data-set was obtained between 1988 and 1998 in a population of 1400 workers age 30 to 60 years, including an overnight sleep polysomnographic in-lab study conducted on two occasions over an eight year period. The dataset contained a computerized analysis of over 300,000 apneas and hypopneas in this non-clinical population. Although strong associations have been demonstrated between sleep disordered breathing and cardiovascular diseases, much is not known regarding the mechanisms by which SDB produces blood pressure changes and increases morbidity. Further analysis of the polysomnography and blood pressure data could yield important insights into the physiologic events responsible for cardiovascular morbidity. Such information could then be used to develop diagnostic tests that identify those people at highest risk and thus who might especially benefit from intervention. This would be of potentially great public health importance, given the prevalence of SDB and the availability of treatments for SDB. DESIGN NARRATIVE: The investigators used the computerized database of the Wisconsin Sleep Cohort to answer the following specific questions. What were the physiologic characteristics of SDB events in the non-clinical population in terms of severity, high airway resistance, obstructive and central components and associated after-effects on EEG arousal and ventilatory overshoots? Did these important elements of the SDB event change as SDB progressed over time? Did the ventilatory or cardiovascular consequences of apnea or hypopnea and its immediate aftermath determine the likelihood of subsequent sleep-disordered breathing events? 2. What were the immediate and long-term cardiovascular consequences of sleep-disordered breathing events; what characteristics of these SDB events (such as oxygen desaturation, arousal, ventilatory overshoot airway resistance, etc.) determined the cardiovascular responses and consequences? 3. What was the effect of aging on SDB and its sequelae as studied in the truly healthy elderly? 4. What role did anatomical characteristics of the upper airway play in determining the frequency and severity and type of sleep-disordered breathing? Did these anatomical determinants differ in the general non-clinical population versus the obstructive sleep apnea (OSA) population? ... in the obese versus the non-obese?
Eligibility:
Study Type: Observational, Natural History, Defined Population
Minimum Age/Maximum Age: 30 Years/60 Years
Genders: Male
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
JeromeDempsey, , University of Wisconsin
Additional Information:
Study ID Numbers: 5095;
Study Start Date: April 1999
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005551
Other Lung Diseases Studies:
1. Strength Training for Obesity Prevention
2. Meditation-Based Treatment for Binge Eating Disorder
3. Genetic Determinants:Low HDL, High Triglycerides, Obesity
4. Genomic Dissection of a QTL Affecting the Lipid Profile
5. Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity with Type 2 Diabetes
Related Studies:
Other Lung Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Sleep Apnea in a Non-Clinical Population
|
|
|
|
|
|
|
|
